NEOG
Neogen Corporation
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$11.83
+1.63%Margins
Gross margin
46.9%
EBITDA margin
19.8%
EBIT margin
-2.5%
Net margin
-0.9%
FCF margin
3.7%
-0.4%
Return on equity
-0.2%
Return on assets
-0.8%
Return on invested capital
0.26x
Asset turnover
$83.2M
Cash from operations
$0.85
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of May 1, 2026